Secteur Celyad Oncology SA Börse Stuttgart
Actions
1C0
BE0974260896
Recherche biotechnologique et médicale
|
Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 0,2640 EUR | +4,35% |
|
+23,41% | +60,63% |
| 14/07 | Celyad Oncology va lever des fonds via un placement privé | MT |
| 15/04 | Prelude Therapeutics Incorporated nomme Charles Morris au poste de Chief Medical Officer, avec effet au 20 avril 2026 | CI |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1,01% | -5,84% | +5,12% | +8,52% | +0,71% | -5,08% | +11,56% | -23,24% | +198,90% | 46,06 Md | |
| +4,05% | +6,60% | +12,68% | +42,03% | +139,80% | +408,93% | +636,31% | +559,99% | - | 38,91 Md | |
| +2,23% | +2,84% | +18,16% | +8,83% | +7,39% | +10,66% | +67,11% | +2,95% | +1 105,28% | 35,57 Md | |
| +3,54% | -2,77% | +19,49% | +27,37% | -9,21% | +5,36% | -10,30% | -17,83% | +176,27% | 33,13 Md | |
| +1,23% | -1,99% | +2,20% | -11,37% | -0,10% | -0,05% | +30,76% | -22,28% | +134,95% | 26,42 Md | |
| +0,94% | -2,09% | +6,71% | +13,16% | - | - | - | - | - | 16,61 Md | |
| +13,14% | +11,54% | +26,72% | +52,51% | +6,83% | +37,17% | +142,98% | +229,46% | - | 15,08 Md | |
| -6,32% | -4,86% | +1,35% | +6,65% | +5,96% | +4,36% | +8,04% | -35,74% | +93,50% | 14,08 Md | |
| +2,53% | +0,55% | +19,81% | +60,74% | -6,20% | +1,81% | -29,55% | -21,59% | +140,04% | 12,81 Md | |
| -0,78% | -4,02% | +33,68% | +16,90% | -4,90% | +110,87% | +552,05% | +265,23% | +2 672,40% | 11,35 Md | |
| +0,38% | +0,26% | +27,90% | +37,84% | +22,35% | +30,09% | -18,15% | -39,33% | +160,66% | 11,19 Md | |
| +3,35% | -1,85% | +20,54% | +34,09% | +12,75% | +33,92% | +8,53% | -43,25% | +160,47% | 10,53 Md | |
| +0,16% | +0,15% | +1,06% | +52,10% | +77,91% | +230,91% | +560,85% | - | - | 10,07 Md | |
| -1,91% | -3,23% | +64,77% | +28,12% | +37,18% | +49,88% | +54,56% | -56,90% | - | 9,77 Md | |
| +0,14% | -3,39% | +12,09% | +26,34% | +41,54% | +137,20% | +402,88% | +89,39% | - | 9,08 Md | |
| +0,34% | +2,84% | +14,13% | +32,31% | +55,45% | +150,55% | +593,42% | +188,75% | - | 8,71 Md | |
| +1,50% | +1,95% | +2,90% | -4,67% | +6,61% | +450,39% | +1 914,23% | +27,81% | - | 8,7 Md | |
| +4,75% | +4,12% | -25,12% | -23,20% | -28,07% | +34,26% | +45,01% | +49,62% | +100,49% | 8,93 Md | |
| +1,42% | +2,21% | +10,44% | +56,56% | +89,74% | +95,26% | +67,00% | +116,87% | +5,93% | 8,76 Md | |
| Moyenne | +1,66% | -1,22% | +14,45% | +24,46% | +25,32% | +99,25% | +279,85% | +74,70% | +449,90% | 17,67 Md | |
| Moyenne pondérée par Capi. | +2,00% | -1,89% | +13,54% | +21,96% | +26,52% | +91,68% | +215,72% | +90,75% | +437,63% |
- Bourse
- Actions
- Action CYAD
- Action 1C0
- Secteur Celyad Oncology SA
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
